ALERT B&C Corporation Announces Results For Its Second Quarter Ended March 31, 2008

    LAVAL, QC, June 1 /CNW Telbec/ - ALERT B&C Corporation (the
"Corporation") (TSX Venture Exchange: ACB) today issued its consolidated
financial results for the three month period ended March 31, 2008.
    There were no revenues during the second quarter of fiscal 2008, but the
Corporations' efforts were dedicated to the release of TRAKER(TM) equipments
in the upcoming quarter. General and administrative expenses, production, and
commercialization and market development costs amounted to $257,401, $51,816
and $39,317 respectively in the second quarter of fiscal 2008 as compared to
$179,455, $97,165 and $16,564 in the same quarter of 2007. For the six-month
period ended March 31, 2008, these costs amounted to $621,678, $156,564,
$90,292 compared to $317,899, $97,165, $20,141 for the same period last year.
For both the second quarter and the six month period ended March 31, 2008, the
major part of these variations were due to the resumption of activities
following the March 2007 financing. These activities include the hiring of
additional employees and consultants for ramping up the production of
instruments and to support the market development of the Corporation's
TRAKER(TM) equipment.
    During the second quarter of fiscal 2008, the Corporation spent $42,847
in research and development expenses (R&D) in refining the development and
prototyping of the TRAKER(TM) equipment. During the same quarter of 2007, no
R&D expenses were incurred. For the six-month period ended March 31, 2008, the
R&D expenses amounted to $80,322, while no R&D expenses were incurred for the
same period last year.
    Net loss for the second quarter of fiscal 2008 was $299,937 ($0.006 per
share) compared to $304,051 ($0.006 per share) for the same period last year.
For the six-month period ended March 31, 2008, the net loss amounted to
$870,347 ($0.018) per share) compared to $453,079 ($0.009 per share) for the
same period last year. On March 31, 2008, the Corporation had cash and cash
equivalents of $279,498 compared to $1,515,314 (inclusive of a guaranteed
investment certificate) at the end of the last fiscal year ended September 30,
    As at March 31, 2008 there were 49,603,860 common shares outstanding.

                                   Three-month period       Six-month period
                                     ended March 31          ended March 31
                                    2008        2007        2008        2007
    Sales                     $        -           -           -           -
    Cost of sales                      -           -           -           -
    Gross profit                       -           -           -           -

      General and
       administrative            257,401     179,455     621,678     317,899
      Production cost             51,816      97,165     156,564      97,165
      Commercialization and
       market development         39,317      16,564      90,292      20,141
      Research and development    42,847           -      80,322           -
      Stock-based compensation    16,105       1,930      26,906       1,930
      Amortization of property
       and equipment              13,461           -      26,185           -
      Amortization of patents      5,575       8,937      11,150      15,944
      Exchange Gain               (4,472)          -      (4,341)          -
      Gain on accounts payable
       settlement                (95,379)          -     (95,379)          -
      Interest income            (26,734)          -     (43,030)          -
                                (299,937)   (304,051)    870,347     453,079
    Net loss and comprehensive
     income                     (299,937)   (304,051)   (870,347)   (453,079)
    Basic and diluted loss
     per common share             (0.006)     (0.006)     (0.018)     (0.009)
    Weighted average common
     shares outstanding
      - basic and diluted     49,603,860  47,957,121  49,603,860  47,957,121

    About the Corporation

    The Corporation is a BioDefence company dedicated to supplying the
BioDefence market with high quality technologies, products and solutions, in
order to improve and maintain the safety and the security of individuals
worldwide. The Intellectual Property owned by Alert B&C, the MAB Technology
has been in use since 2001 by a variety of groups and is a worldwide
recognized technology. The products offered by the Corporation are Biological
and Chemical detection and identification equipment, the TRAKER(TM), designed
for the identification of dangerous and toxic agents. For more information
about the Corporation visit our new website at
    This press release contains forward-looking statements, which reflect the
Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual events
could differ materially from those projected herein. Investors should consult
the Corporation's quarterly filings and annual reports for additional
information on risks and uncertainties relating to these forward-looking
statements. The reader is cautioned not to rely on these forward-looking
statements. The Corporation disclaims any obligation to update these
forward-looking statements

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.
    %SEDAR: 00012523E

For further information:

For further information: Investor relations: Dr. Suzanne L. Lebel,
Chairman & Executive Vice-President, ALERT B&C Corporation, (450) 688-4499,
Fax: (450) 688-9100,; Mr. Kurt G.J. Soost, President & CEO,
ALERT B&C Corporation, Toll-free: 1-866-802-0366 (Canada), (403) 802-0366, 
Fax: (403) 802-0766,; Media relations: Jean-Pierre Trudel,
President, Jean-Pierre Trudel & Associates Inc., (514) 347-6111, Fax: (514)

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890